Rephonic
Artwork for Beyond Biotech

Beyond Biotech - the podcast from Labiotech

Labiotech
Biotechnology
Clinical Trials
Alzheimer's Disease
Gene Therapy
Oncology
Artificial Intelligence
Autoimmune Diseases
Neurodegenerative Diseases
Psychedelics
Cancer Treatment
Drug Development
Obesity
AI In Drug Discovery
Cell Therapy
Rare Diseases
Schizophrenia
Cardiovascular Disease
Drug Discovery
Stem Cell Therapy
Cancer

Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.

PublishesWeeklyEpisodes219Founded4 years ago
Number of ListenersCategories
Tech NewsNews

Listen to this Podcast

Artwork for Beyond Biotech

Latest Episodes

Welcome to a special three-part series called 'The Metabolic Moment'.

In just a few years, GLP-1 drugs have become a phenomenon. They’ve transformed how we treat diabetes and obesity, created one of the biggest markets in pharma, and sparked a cultu... more

YouTube

Saudi Arabia has spent the last four years building one of the most ambitious biotech gatherings in the region: the Riyadh Global Medical Biotechnology Summit. This September, the fourth edition brought together delegations from more than 57 countrie... more

YouTube

AI has been one of the biggest buzzwords in biotech for years now — but for all the technological progress, actual R&D productivity gains have been hard to find, and the cost of developing a new drug keeps climbing. My guest today believes that's bec... more

YouTube

By 2050, nearly half the world's population is expected to be myopic, with around a billion people projected to progress to high myopia — a leading cause of irreversible vision loss later in life. Children face a narrow window in which to intervene, ... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Abdulaziz Aldayel
Nanomedicine researcher at the King Abdullah International Medical Research Center (KMARC) and Deputy Chairman of Collaboration Partnerships for RGMBS
KMARC, Riyadh
Episode: Saudi Arabia's biotech momentum: inside RGMBS 2026
Brian Alexander
CEO of Valo Health
Valo Health
Episode: How Flagship's Valo is reshaping AI drug discovery with human data
Thomas Ruggia
President and CEO of Theialife
Theialife
Episode: Theialife’s race to bring a childhood myopia treatment to market
Randy Teel
CEO of Arvinas
Arvinas
Episode: The best biotech conversations you missed this summer
Per Lundin
Executive at Evox
Evox
Episode: The best biotech conversations you missed this summer
Laurent Lévy
CEO of Nanobiotix
Nanobiotix
Episode: The best biotech conversations you missed this summer
Andy Parker
Founder of Step Pharma
Step Pharma
Episode: The best biotech conversations you missed this summer
Gene Mack
Founder of Gain Therapeutics
Gain Therapeutics
Episode: The best biotech conversations you missed this summer
Nerissa Kreher
Chief Medical Officer at Alltrna
Alltrna
Episode: The best biotech conversations you missed this summer

Host

Dylan Kissane
Host of Beyond Biotech

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#79
United States/News/Tech News
Apple Podcasts
#48
United Kingdom/News/Tech News
Apple Podcasts
#58
Germany/News/Tech News
Apple Podcasts
#71
Italy/News/Tech News
Apple Podcasts
#133
France/News/Tech News
Apple Podcasts
#36
Saudi Arabia/News/Tech News
Apple Podcasts
#38
Japan/News/Tech News
Apple Podcasts
#43
India/News/Tech News
Apple Podcasts
#54
Hong Kong/News/Tech News
Apple Podcasts
#55
Denmark/News/Tech News
Apple Podcasts
#59
Israel/News/Tech News
Apple Podcasts
#66
South Africa/News/Tech News
Apple Podcasts
#71
Singapore/News/Tech News
Apple Podcasts
#71
Netherlands/News/Tech News
Apple Podcasts
#98
Russia/News/Tech News
Apple Podcasts
#112
Taiwan/News/Tech News
Apple Podcasts
#127
South Korea/News/Tech News
Apple Podcasts
#130
Mexico/News/Tech News
Apple Podcasts
#135
Sweden/News/Tech News
Apple Podcasts
#171
Finland/News/Tech News
Apple Podcasts
#171
New Zealand/News/Tech News
Apple Podcasts
#173
Switzerland/News/Tech News
Apple Podcasts
#194
Spain/News/Tech News
Apple Podcasts
#225
Belgium/News/Tech News

Talking Points

Recent interactions between the hosts and their guests.

This nonprofit is building the ecosystem to cure epidermolysis bullosa
Q: Could you describe a concrete collaboration, like the LEO Pharma and Replay deal, and what it demonstrates about your model?
The collaboration shows how DEBRA Research educates and connects pharma to the EB landscape, bringing patient perspectives to the table, identifying opportunities, and helping accelerate development through strategic introductions and shared insights, which can trigger sustained industry interest and subsequent investment.
This nonprofit is building the ecosystem to cure epidermolysis bullosa
Q: What was the rationale behind launching equity investments instead of only grants?
Equity investments are part of a broader strategy to broaden the clinical pipeline and accelerate bringing therapies to patients; as a patient-focused investor, DEBRA Research aims to support value-creating opportunities while leveraging its network and expertise to guide and de-risk projects for commercialization.
How Flagship's Valo is reshaping AI drug discovery with human data
Q: What role do partnerships play in your strategy, and how do you decide what to do with partners versus internally?
Partnerships allow tackling biotherapeutic areas where external expertise and shared governance accelerate progress, while internal programs focus on higher-risk or novel biology where we can own the development up to clinical proof of concept. The mix balances biology risk with chemistry capability and leverages governance with partners like Novo Nordisk or EMD Serono to move targets forward.
How Flagship's Valo is reshaping AI drug discovery with human data
Q: How does Valo's platform differ from traditional AI approaches in pharma?
Valo starts with massive, longitudinal human data and uses two connected platforms—human causal biology to identify and understand disease subgroups and predictive chemistry to optimize molecules—so the modeling is anchored in real-world biology and observable patient outcomes rather than solely in preclinical models or literature alone.
How Flagship's Valo is reshaping AI drug discovery with human data
Q: Why do you think AI-driven productivity gains in drug discovery haven't shown up as dramatically as promised?
The bottlenecks are primarily in clinical development, where endpoints and standard-of-care dynamics have become more complex, and signals are harder to detect in larger, longer trials. AI can speed chemistry and data processing, but translating a signal into a regulatory-approved therapy requires navigating clinical endpoints and real-world practice, which dampens accelerative effects.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Beyond Biotech

What is Beyond Biotech about and what kind of topics does it cover?

This show centers on the biotech industry, featuring in-depth conversations with company founders, executives, scientists, and researchers about cutting-edge research, translational challenges, and the evolving biotech ecosystem. Episodes often explore drug discovery, translational biology, manufacturing, data and AI in life sciences, and strategic business topics like partnerships, funding, and go-to-market strategies. Notable throughlines include practical industry insights from seasoned leaders, emphasis on bridging preclinical work to human outcomes, and a recurring focus on scalable platforms, data integrity, and translational risk management. A standout aspect is the broad mix of technical depth and business strategy, frequently pairi... more

Where can I find podcast stats for Beyond Biotech?

Rephonic provides a wide range of podcast stats for Beyond Biotech. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Beyond Biotech and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Beyond Biotech get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Beyond Biotech, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Beyond Biotech?

Rephonic provides comprehensive predictive audience data for Beyond Biotech, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Beyond Biotech have?

To see how many followers or subscribers Beyond Biotech has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Beyond Biotech?

These podcasts share a similar audience with Beyond Biotech:

1. BioCentury This Week
2. The Long Run with Luke Timmerman
3. Biotech Hangout
4. The Readout Loud
5. Biotech 2050 Podcast

How many episodes of Beyond Biotech are there?

Beyond Biotech launched 4 years ago and published 219 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Beyond Biotech?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Beyond Biotech?

Rephonic pulls ratings and reviews for Beyond Biotech from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Beyond Biotech?

Rephonic provides full transcripts for episodes of Beyond Biotech. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Beyond Biotech?

Recent guests on Beyond Biotech include:

1. Abdulaziz Aldayel
2. Brian Alexander
3. Thomas Ruggia
4. Randy Teel
5. Per Lundin
6. Laurent Lévy
7. Andy Parker
8. Gene Mack

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days